Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD

Evgenia A. Kochetkova (Strasbourg, France), Ludmila G. Ugay, Evgenia A. Kochetkova, Vera A. Nevzorova, Yuliya V. Maistrovskaia

Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Session: Biomarkers and phenotypes of COPD and comorbidities
Session type: Poster Discussion
Number: 4612
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Evgenia A. Kochetkova (Strasbourg, France), Ludmila G. Ugay, Evgenia A. Kochetkova, Vera A. Nevzorova, Yuliya V. Maistrovskaia. Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD. Eur Respir J 2016; 48: Suppl. 60, 4612

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Adipokines in end-stage lung diseases: The crosstalk between bone and adipose tissue
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013


Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016


Molecular mechanisms of lung tissue remodeling in progression of idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010

Biochemical markers of bone remodeling in children with chronic lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 262s
Year: 2006

Possible role of liver disease and respiratory insufficiency in osteopenia in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013

Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Increased levels of glycosaminoglycans in lungs from patients with IPF
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

The effects of tobramycin on pulmonary fibroblast function
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016

Chemical exposure triggering connective tissue disease with lung involvement
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015


Markers of pulmonary vascular compromise predict survival in interstitial lung disease (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008


Osteoporosis and adipose tissue expression of adipokines and osteoprotegerin in severe chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013


¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007



Premature aging and skeletal muscle dysfunction in COPD patients: Development of a cell culture model
Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD)
Year: 2014


Altered extracellular matrix in transplanted lungs as a potential marker for chronic rejection
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

Hepatic function markers in COPD as a systemic implication of the disease
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008

The value of biomarkers in the rheumatoid arthritis related interstitial pneumonia
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013